In 2021 we had the vaccine, more infections more hospitalized and more deaths and still no outpatient treatment.
Fact is:: As UK data clearly shows vaccination fuels the pandemic. Vaccinated - in fact gene therapeutic - get up 5x more often CoV-19 and hence speed up the CoV-19 wave.
This effect first could see in July already !!!
The historians will soon name this F/R/B terror phase using the correct terminology. And I hope we will see many folks going to jail.
I'm not sure why the US government would talk about eradication. Not many people I know have ever had that as more than a hope, and one that was dashed with the emergence of delta, let alone omicron.
I have not read that. On the contrary, diseases such as rubella have been eradicated even though there were variants and rubella infected large fractions of the population. COVID does not change as quickly as influenza. There are only a few major variants of COVID. For all variants, the present vaccines reduce the transmission rate well below 1. So if everyone was vaccinated, the disease would decrease exponentially. It would go extinct in humans. Perhaps reservoirs in species such as white tailed deer would periodically reinfect humans, but that should be controllable. COVID does not survive on surfaces or in dirt.
If the present vaccines fail to reduce transmission below 1, new mRNA vaccines can be developed quickly, which will accomplish that.
Nearly every hospital patient is unvaccinated, with all of the variants. Vaccinated people usually suffer only a mild case that does not need hospitalization.
Jed lives in Disney world::
Most people in UK hospitals are vaccinated.....
UK has a law that forbidds cheating about medical facts. In USA cheating is the business model....
In 2020 340,000 died from Covid according to the CDC. In 2021 an estimated 500,000 have died of Covid according to the CDC. In 2021 we had the vaccine, more infections more hospitalized and more deaths and still no outpatient treatment.
There you go again!!! Do you not realize that nearly all of those 500,000 dead people WERE NOT VACCINATED?!? How the heck do you expect a vaccine to protect people who refuse to take it? This is like expecting seat belts to save the lives of people who refuse to buckle them up. Do you think seat belts work magically to stop people from going through the window when the belt is not used?
If everyone were vaccinated, ~475,000 of those dead people would still be alive. This is a pandemic of the unvaccinated. It is preventable.
I have not read that. On the contrary, diseases such as rubella have been eradicated even though there were variants and rubella infected large fractions of the population. COVID does not change as quickly as influenza. There are only a few major variants of COVID. For all variants, the present vaccines reduce the transmission rate well below 1. So if everyone was vaccinated, the disease would decrease exponentially. It would go extinct in humans. Perhaps reservoirs in species such as white tailed deer would periodically reinfect humans, but that should be controllable. COVID does not survive on surfaces or in dirt.
If the present vaccines fail to reduce transmission below 1, new mRNA vaccines can be developed quickly, which will accomplish that.
The only time r is below 1 is during the summer months as September rolls around it starts to move up. The vaccines have nothing to do with this. Covid is seasonal. Just like the flu and winter colds r always goes up as we enter fall.
The only time r is below 1 is during the summer months as September rolls around it starts to move up.
Unluckily also idiotic behavior fuels a wave. In this years summer holidays (August!!!) some 10'000 "secondos" from Kosovo war refugees traveled back to their origin nation and spent 1 week in clubs without interrupt. This did fill the Zürich ICU much more than the recent 10x larger wave. We also could not bring back 50 more ICU people, as we had to keep some local backup capacity....So in reality this was the worst wave ever at least for hospitals in Zürich.
Just to remind people: Switzerland did host between 200'000 and 300'000 refugees during the Kosovo war and most decided to stay here. This is the largest ever relatively added population group in any European country so far. Next close is the Ukrainian migration of so called Russian Germans to BRD. But this happened over several years.
ChemRar Group announces the Russian Avifavir® drug is effective against variants of COVID-19, including Delta and Omicron
ChemRar Group announces the Russian Avifavir® drug is effective against variants of COVID-19, including Delta and Omicron
Avifavir® is effective against various variants of coronavirus, including Delta and Omicron, as it affects the highly conservative and mutation-resistant replication systems of RNA virus (RdRp).
The virus is incapable of developing resistance to favipiravir even with long-term exposure on infected cells, as has been confirmed in clinical trials. This provides Avifavir® with a major advantage not only over highly specific biologics but also over many other similar nucleoside products.
Moscow, December 27, 2021 — ChemRar Group announces the Russian Avifavir® (INN: favipiravir) drug is effective against various variants of SARS-CoV-2 (coronavirus), including Delta and Omicron, as it affects the highly conservative and mutation-resistant replication systems of RNA virus (RdRp) via three complementary mechanisms, resulting in complete blockade of the viral infection.
In addition, the virus is incapable of developing resistance to favipiravir even with long-term exposure on infected cells, as has been confirmed in clinical trials. This provides Avifavir® with a major advantage not only over highly specific biologics but also over many other similar nucleoside products prone to inducing rapid evolution of resistant clinical variants.
The problem of rapid mutation is particularly typical of RNA viruses, such as SARS-CoV-2 (coronavirus). Most of the mutations are found in the spike protein structure, in particular in two of its key parts that are recognized by the human immune system.
A meta analysis of 23 COVID-19 treatment studies for favipiravir is demonstrating a 47% improvement when favipiravir is used in early treatment of coronavirus. This analysis is available at: https://c19favipiravir.com/meta.html
In June 2020, with the support of the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), ChemRar Group specialists developed and were the first in the world to release Avifavir® (INN: favipiravir), a direct antiviral for COVID-19 treatment, to the Russian and international markets. The product’s efficacy has been confirmed in a full-scale clinical trial in Russia involving 460 COVID patients. Avifavir® has been supplied to more than 15 countries around the world.
Clinical trials of Avifavir® have demonstrated its anti-COVID properties, such as alleviating symptoms and cut the duration of the disease by half compared to standard therapy.
In particular:
Avifavir® is demonstrating the best results in COVID treatment when used in the first 3-5 days after first symptoms;
After the first 4 days of treatment, 65 % of patients on Avifavir® tested negative for coronavirus, twice the rate of the standard treatment group. By day 10, the number of negative patients had reached 90 %;
In 68 % of patients on Avifavir®, body temperature normalized earlier (on Day 3) compared to the control group (on Day 6).
Median time to clinical improvement with Avifavir® was 7 days vs. 10 days in the standard treatment group.
In addition, the results of Avifavir® in patients with COVID-19 are being closely monitored in real-world clinical practice. A retrospective review of favipiravir’s efficacy and safety is currently under way in 40,000 patients exposed to the product in an outpatient or inpatient setting.
In 2020–2021, potential of favipiravir against coronavirus infection was actively investigated in more than 50 clinical trials involving around 5,000 patients in Russia, Japan, China, India, Thailand, Turkey, Iran, Saudi Arabia, EU countries and Latin America. To date, the PubMed database of international medical and biological literature contains almost 900 peer-reviewed favipiravir-related papers. At least 700 of them were published in the last 1.5 years. These publications speak for the high efficacy and safety of favipiravir against COVID-19.
Elena Yakubova, Medical Director of ChemRar Group, commented:
“Having accumulated extensive experience with Avifavir® in patients infected with COVID both from clinical trials and real-world clinical practice, we see that taking Avifavir® in the first 3–5 days after infection leads to a milder disease in most cases and prevents hospitalization. Over the past 17 months, more than 4 million patients have been treated with favipiravir worldwide. The product was well tolerated with no new adverse events, which confirms the high safety of favipiravir”.
To date, vast body of information has been accumulated in the scientific literature on various aspects of the favipiravir pharmacology as the product has been well studied, including its mechanisms of action, activity in vitro and in vivo, clinical efficacy, safety, cost-effectiveness, potential for combination therapy, analytical control methods, etc. A series of clinical trials in 2020-2021 have provided objective evidence for the efficacy and safety of favipiravir as treatment for COVID-19.
If therapy begins in the first days after the onset of disease, the product significantly increases survival rate, reduces viral load, need for artificial ventilation, and length of hospital stay.
Robert Redfield, a renowned American virologist and former director of the U.S. Center for Disease Control and Prevention (2018–2021), notes: “Avifavir® has been shown to be effective against COVID-19 in clinical trials and medical practice. Recently additional direct acting antiviral have been developed. Studying the combination of Avifavir® with other antivirials such as Paklovid (Pfizer) could offer even better therapeutic options for those at higher risk of COVID-19 disease progression, reduce the likelihood of drug-resistant virus mutations, and increase the time after diagnosis when therapy can be effective”.
References to studies supporting the efficacy of favipiravir against COVID-19:
In a multicenter randomized phase II/III clinical trial in patients with moderate COVID-19 (NCT04434248), Avifavir provided effective clearance of SARS-CoV-2 virus in 62.5 % of patients within 4 days, was safe and well tolerated (Ivashchenko А.А. et al. Avifavir for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial. Clin Infect Dis. 2021 Aug 2;73(3):531-534. doi: 10.1093/cid/ciaa1176.). Now we can summarise and supplement both the ChemRar Group data on the use of the product and the findings of extensive scientific research with the product performed around the world.
A systematic meta-analysis of 11 clinical trials has demonstrated that favipiravir causes effective clearance of the SARS-CoV-2 virus by day 7 and promotes clinical improvement within 14 days (Manabe et al. Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis. BMC Infect Dis. 2021; 21(1):489.).
In a randomized, blind, placebo-controlled phase III study of favipiravir efficacy and safety in 156 COVID-19 patients with moderate-to-severe pneumonia (Japan), the median time to patient recovery was 11.9 days in the favipiravir group and 14.7 days in the placebo group, with a statistically significant difference (p = 0.0136) (Shinkai M. et al. Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial. Infect Dis Ther. 2021 Aug 27; 1-21.).
Inclusion of favipiravir in the national COVID-19 treatment protocol in Turkey resulted in a pronounced, statistically significant decrease in ICU hospitalization rates from 24 % to 12 % (Guner et al. ICU admission rates in Istanbul following the addition of favipiravir to the national COVID-19 treatment protocol. North Clin Istanb. 2021; 8(2):119.).
In a retrospective study conducted in specialized public hospitals in Saudi Arabia, the median time to discharge for patients with COVID-19 was 10 days in the favipiravir group compared to 15 days in the maintenance therapy group, across all grades of COVID-19 severity (Alamer et al. Effectiveness and safety of favipiravir compared to supportive care in moderately to critically ill COVID-19 patients: a retrospective study with propensity score matching sensitivity analysis/ Curr Med Res Opin. 2021; 37(7):1085.).
In a randomized, open-label, parallel, multicenter phase III study of 150 patients with mild to moderate COVID-19 conducted in India, the median time to cessation of virus excretion was 5 days versus 7 days, and the median time to clinical recovery was 3 days versus 5 days for favipiravir and control, respectively (Udwadia et al. Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial. Int J Infect Dis. 2021; 103:62.).
Favipiravir has demonstrated efficacy and safety in treatment of mild to moderate COVID-19 in outpatients and hospitalized patients: the median time to clinical improvement was 6.0 days (IQR 4.0; 9.3) in the favipiravir group and 10.0 (IQR 5.0; 21.0) days in the SOC group. The rate of viral elimination on Day 5 in the favipiravir group was significantly higher than in SOC group: 81.2% vs. 67.9% (RR 1.22; 05% CI 1.00-1.48; P=0.022). (Phase 3 trial of coronavir (favipiravir) in patients with mild to moderate COVID-19. Am J Transl Res 2021;13(11):12575-12587)
In 2020–2021, potential of favipiravir against coronavirus infection was actively investigated in more than 50 clinical trials involving around 5,000 patients in Russia, Japan, China, India, Thailand, Turkey, Iran, Saudi Arabia, EU countries and Latin America.
In Japan Avigan (its original name) did show no clear signal. But it has been used in later stage.
But after Avigan you should have no sex for the next 6 months...With Ivermectin its no problem....
Israel sees an explosion in cases too. Also the positive rate just doubled. Same for all European countries including Sweden!
So we all are in the final run now!
Unluckily also idiotic behavior fuels a wave.
Just once more infamous Ischgl pub "Kitzloch" again. (Very same pub that was responsible for Europe wide outbrake of Alpha back in February/March 2020.)
Despite 2G rule in Austria in ski resorts, a bar keeper has been tested positive on Omicron and potentially numerous guests have been infected with Omicron.
Simply no lesson learned!
Double counting? Over 800,000 Americans have died from Covid 19. In 2020 340,000 died from Covid according to the CDC. In 2021 an estimated 500,000 have died of Covid according to the CDC. In 2021 we had the vaccine, more infections more hospitalized and more deaths and still no outpatient treatment.
You are double-counting because instead of noting the fewer people who have died due to vaccines, you are saying anyone catching COVID from a vaccinated person is dying because of the vaccine.
However many breakthrough infections, it is never more than the infection rate from that same person without a vaccine, so the vaccine is not killing those people.
Vaccines save lives by reducing the severity of COVID for those who are vaccinated. Anything else is problematic long-term because of variants etc. Vaccines (unless 95% effective with high vaccination rates) do not make endemic diseases go away. There is no chance of at the moment of a 95% effective vaccine that stays like that against variants - and no-one sensible ever said or thought there was.
THH
Display MoreYou are double-counting because instead of noting the fewer people who have died due to vaccines, you are saying anyone catching COVID from a vaccianted person is dying because of teh vaccine.
However many breakthrough infections, it is never more than the infection rate from that same person without a vaccine, so the vaccine is not killing those people.
Vaccines save lives by reducing the severity of COVID for thoe who are vaccinated. Anything else is problematic long-term because of variants etc. Vaccines (unless 95% effective with high vaccination rates) do not make endemic diseases go away. There is no chance of at the memoment of a 95% effective vaccine that stays like that against variants - and no-one every said or thought there was.
THH
Ah yes, and now the infamous Huxley word salad two step.
1 I never said the vaccine killed anyone I said vaccinated people infected with Covid are spreading the virus. The virus kills around a high of 2%
2. I pointed out 340,000 American died in 2020 and an estimated 500,000 in 2021 while we had a vaccine.
3 I said the vaccine has a positive affect on hospital cases and deaths, just not to the extent you believe.
4 I gave you the only numbers that count deaths before and deaths after
3 I said the vaccine has a positive affect on hospital cases and deaths, just not to the extent you believe.
4 I gave you the only numbers that count deaths before and deaths after
FM1
I'm happy for you to quote unrelated statistics.
You said
You still don't get it. Spread of the virus and the timeing of it is a pattern and has been for 2years. Around each seasonal change we see a sharp rise in cases and then a sharp drop after Covid reaches about 20% saturation of the population. Omicrom looks to be a different beast as it went as high as 30.1 % saturation before the decline began in south africa. Both natural immunity and vaccinated have seen large breakthroughs. The vaccines have no effect on the spread of the virus. Hospitalized and deaths the vaccines show a small positive effect.
You have now got rid of "small" so I'm happy to agree with you. We can discuss the (large) size of the positive effect numerically if you wish. And while mentioning deaths before and after as you have is misleading, we can both agree it is just they way you write and not an argument to be taken seriously.
Happy New Year.
THH
Just once more infamous Ischgl pub "Kitzloch" again. (Very same pub that was responsible for Europe wide outbrake of Alpha back in February/March 2020.)
Despite 2G rule in Austria in ski resorts, a bar keeper has been tested positive on Omicron and potentially numerous guests have been infected with Omicron.
Simply no lesson learned!
The positive person was not tested with Omicron. Was in the news all over the place…
If the present vaccines fail to reduce transmission below 1, new mRNA vaccines can be developed quickly, which will accomplish that.
That is certainly a hope but not one Western governments seem interested in funding at the moment.
Without fast worldwide vaccination (possibly even with it, from animal reservoirs) we will have regular new variants that evade vaccines - at least until the vaccine tech has got a good deal more sophisticated than current. We can hope for that in the future.
Data Continues to Suggest Omicron Milder in Children Despite Rapid Growth in Infections
Although highly transmissible, early studies and multiple reports suggest a milder impact from the Omicron variant of concern on adults. However, across multiple states, reports of a 50% increase in pediatric hospitalization raise real concerns for children. In New York City alone health authorities report a 4-fold increase in pediatric hospitalization, totaling 68 children. However, no evidence has yet to manifest indicating the pathogen is not mild in effect. By all accounts thus far Omicron appears milder than the Delta variant. Of course, public health services and hospitals are on full alert in case the trend shifts for the worse.
As Omicron surges, vying for top variant, the Centers for Disease Control and Prevention (CDC) recently adjusted downward their estimate as to the extent of the new variant’s reach. Estimates for the week ending Dec. 18 were lowered from 73% down to 59% of all COVID-19 cases nationwide. Yet in the Northeast, Omicron appears to accelerate its pervasiveness—the new super mutant is responsible for about 90% of cases in New York City.
Data Suggests Milder Variant So Far
These updates come courtesy of the New York Times, quoting Dr. David Rubin with Children’s Hospital of Philadelphia, “I think the important story to tell here is that the severity is very low, and the risk of serious and significant disease appears to be lower.”
The New York Times emphasizes vaccination, noting that children 5 and under aren’t yet eligible for the vaccine. Consequently, children are less protected as compared to adults. The American Academy of Pediatrics reported a 50% increase in cases—totaling 199,000 by Dec. 23. The AAP reports about 10% of children across America have been infected with SARS-CoV-2 since the pandemic onset.
Throughout the pandemic children were hit far less hard than adults, however, last week 1,200 were infected as compared to 800 by the end of Nov., reports the New York Times. A key point of the New York Times article was a prompt for vaccination as the nation’s top newspaper declared:
“In interviews, hospital leaders and intensive care doctors said almost all children hospitalized with COVID had one thing in common: They were not vaccinated or were under-vaccinated.”
Meanwhile, due to the highly contagious nature of Omicron, Dr. Patricia Manning, chief of staff at Cincinnati Children’s Hospital was quoted “We are just holding our breath and preparing for an impact tsunami.” Another doctor, Dr. James Schneider, who leads the pediatric intensive care unit at New York Children’s Medical Center declared based on unfolding observations in the ICU “vaccination is the most important thing you can do to protect your child from the disease of this virus.” He reported that he had five to eight children in the ICU with COVID-19, up from zero to one last month.
The New York Times piece shared that SARS-CoV-2 positivity rates track as high as 20% in children, yet “the vast majority were asymptomatic and arrived at the hospital with other health problems.” Meanwhile, CHOP’s Dr. Rubin reports although Omicron dominates the southwestern part of Pennsylvania actual pediatric cases in the ICU have dropped in half since the fall.
Rubin suggested to the New York Times that fear-driven overreactions aren’t warranted based on the data thus far declaring “While we are definitely seeing an increase in transmission in children, vaccinated and unvaccinated, I think we need to be very careful to avoid sending the message that Omicron poses an unusual risk to children.”
Vaccination Doesn’t Stop Community Transmission
CHOP’s Dr. Rubin, a principal investigator for the PolicyLab COVID-19 forecasting model, went on the record that they observe Omicron-based transmission in both unvaccinated and vaccinated alike, while Dr. James Versalovic, a chief pathologist at Texas Children’s Hospital in Houston reported that Omicron spreads rapidly among the fully vaccinated. He notes that they haven’t seen any sharp rise in hospitalization of children, despite the rapidly growing numbers of infections.
Why no Discussion of Risk-Benefit Analysis?
Of course, it’s too early to tell, as the deep winter could bring a far greater number of infections and complications. It’s just too early to assess the true risks to children, suggests the New York Times piece. Noteworthy, the New York Times failed to raise any of the risks associated with child vaccination. For example, overwhelming data now reveals that risk for adverse events such as myocarditis are higher in younger people. Any pediatric vaccination program requires a proper risk-benefit analysis.
Are the risks of not getting vaccinated greater than the risks associated with the Omicron variant of SARS-CoV-2? Thus far all data suggests a milder pathogen than Delta, but again, that could change. The New York Times reported 790 Americans under the age of 18 have died since the onset of the pandemic. The great majority of these cases involved comorbidities. Of course, one death is a tragedy, and children along with the elderly represent some of society’s most vulnerable.
TrialSite will continue to track the following questions:
Just how severe or mild is Omicron for adults? Children?
Why aren’t mainstream media such as the New York Times talking at all about vaccine risks, particularly for cardiovascular issues such as myocarditis?
If the Omicron variant continues to indicate milder strain how will that impact the risk-benefit analysis for vaccination, or not?
For those rare instances, where children do end up in the hospital and what are the optimal pediatric treatment courses? Are hospitals and health systems ready to care for children proactively
The positive person was not tested with Omicron. Was in the news all over the place…
Unfortunatley in the news today.
You have to scroll down a bit.
German Scientist Who Questioned Vaccine Ingredients, Dies Mysteriously
A German chemist died just days after publishing a video in which he reported that vaccines contained graphene oxide, a dangerous substance found on masks that were recalled in France and Canada. His death was announced to the public by his wife in a video on Telegram, a popular messaging application. Some people think his death was linked to the video, while the mainstream media and its fact checkers reject this as conspiracy talk.
In his videos, Dr. AndreasNoack, who specialized in activated carbon, explained that the experiments on vaccines are done in petri dishes and that is why you cannot foresee the damage their ingredients will cause to the human body. However, most of the supposed fact check websites, such as Reuters, point that these claims are unfounded. Other media around the world, including France 24, refute that graphene is utilized by the COVID-19 vaccines.
Introduction to Graphene and Dr Noack’s hypothesis
Graphene, a light, material made of carbon atoms linked together in a repeating hexagonal pattern, is considered as two-dimensional because of its thin properties. A robust conductor of electricity and heat, certain industries utilize the metal, including electronics, aerospace and medicine. The strongest and most conductive material in the world is said to be graphene. Graphene oxide is a material that is used instead of graphene, since graphene is expensive and hard to produce. Graphene oxide is cheaper than graphene, but apparently just as effective.
In medicine, graphene and alternatives are used in gene and small molecular drug delivery. There is research about its usage in vaccines. To improve immunogenicity of the antigen and reach longer immunity, adjuvants (substances which enhance the body’s immune response to an antigen) and carriers are added to vaccine formulations.
However, some adjuvants have limited functionality, thus an apparent need for novel adjuvants. Recently, a group of Chinese researchers discussed the potential of graphene oxide as an adjuvant to be used in vaccines since it is already used in the delivery of biomolecules and it is successful at loading and delivering antigen, therefore, it has a potential for activating the immune system. However, significant risks are involved with such exposure—such as the potential for cell death by accumulating in the biological fluid. However, various surface modification protocols are purportedly used to mitigate limitation of use due to safety.
In his viral video, the scientist, Dr. Noack explained that graphene oxide is a new material and toxicologists were not aware of it yet, nor of possible risks. He indicates that the substance, graphene oxide, acts like a razor in veins and cuts the veins from inside, and causes internal bleeding. Athletes, who have faster-flowing blood, are especially affected, he said. While more evidence is needed, there are claims of athlete deaths that are being linked to the vaccines.
Such claims must be proven, however. Accusations by individuals without collective scientific backup are just one-off claims and probably misstatements. That a pharmaceutical company could trick the major regulatory bodies around the world is highly unlikely.
Partner’s Statements About Dr. Noack’s Death
Dr Noack’s death was announced and explained by his partner via Telegram in two different videos. In the first video, published on November 27, 2021, his partner indicates that three days after the video in which he reported that vaccines contained graphene oxide, Dr. Noack was attacked brutally. His agitated and visibly pregnant partner describes the assault as extremely unexpected. Dr. Noack did not survive the attack.
In a second video published on November 29, 2021, via Telegram, his partner made another statement about the doctor’s death. She explained that when she talked about a violent attack, she did not mean a physical attack, but rather an attack with an energy weapon from a distance. At least, this is what she believes occurred. She explains that 20 to 30 minutes after the video’s publication, Dr. Noack went to the kitchen and didn’t come back. So, she went to check on him and after that, he started swaying. After that, the electricity went off, she says, and he collapsed into her arms. He subsequently stopped breathing. The paramedics came and he was transferred to a hospital, where he later died.
Doctors explained that he had died of a heart attack as reported in the Daily Expose. Various fact check organizations have published debunks of many of this media platform’s stories.
Earlier this year, Great Game India reported on U.S. congressman Thomas Massie pointing out that the COVID-19 “fact-checking” project conducted by a Facebook-partnered website, Factcheck.org, is actually funded by the Robert Wood Johnson Foundation, which holds $1.9 billion in Johnson & Johnson stock. The RWJ Foundation is headed by the former CDC director, Richard E Besser. The Foundation denied any conflicts of are interest involved.
Noack’s partner believes he was attacked with a ‘direct energy weapon,’ a weapon that uses concentrated electromagnetic energy. This seems a bit outlandish, but one cannot speculate as this is a specialized and controversial topic. Report 24 conducted research into the doctor’s death, which occurred at his home in Austria. They found that he died on November 26, 2021. The cause of death was not clear, but based on the knowledge they have, they ruled out suspected murder. The police informed reporters that no suspected murder of a male was recorded on the day Dr. Noack died. After he died, his Telegram channel continued to publish.
On the 10th of December, Dr Ariyana Love, naturopathic doctor and investigative journalist, published an article referring to a December 3rd video leak from an anonymous source. The video contained in the article purports to confirm that graphene hydroxide looks like razor blades under dark field microscopy.
Graphene Oxide in COVID-19 Vaccines
Reuters published a fact check about graphene oxide in COVID-19 vaccines, comparing the claims to the official ingredients declared by multiple vaccine manufacturers. Pfizer’s board includes ex-Facebook director Dr Susan Desmond-Hellman, and ex-Reuters CEO, James C Smith. Reuters is a significant part or member of the controversial Trusted News Initiative.
The Reuters article states that the claims related to graphene oxide began with a report by Pablo Campra Madrid, a professor at the University of Almeria, Spain, in June 2021. His report was independent of the university. He studied a vial of Pfizer-BioNTech vaccine with an unknown origin which came to him by post. He reported that he examined the vaccine under the microscope and compared what he saw to images of graphene hydroxide. He concluded that they looked similar. He stated that he studied one vial, and results were non-conclusive. In November 2021, Campra released a technical analysis report about graphene oxide in vials.
Not on the Company Ingredients List
A statement made by Pfizer indicated that the vaccine does not contain such material. Graphene oxide does not appear on the ingredients lists of any of the available COVID-19 vaccines, including the Pfizer/BioNTech vaccine. However, it was reported by TrialSite that Pfizer is fighting to have vaccine data kept secret from the general public, for decades.
According to Reuters, Matthew Diasio, an American Chemical Society Congressional Science & Engineering Fellow, explained on Twitter that the substances that include graphene oxide have a dark color like dark brown or black. However, Pfizer-BioNTech vaccines are transparent. If they were to involve graphene oxide, they should have a darker color, Matthew Diasio indicated. Earlier this year, Japan put Moderna vaccines on hold, due to discovering unusual black speck contaminants. Two people had died after taking vaccines from the same batches.
Alleged Connections to Noack’s Death
Dr. Noack was arrested back in 2020 during a live session on YouTube. It was rumored that he wasn’t complying with the German lockdown rules and was administering medical assistance to protestors during lockdown protests. The arrest took place after the ‘’Infection Protection Law’’ passed the German Parliament. People who were watching the live stream speculated that he was arrested due to his opinions. A police spokesperson explained that they were searching the building for another person and arrested him due to an unrelated matter. A strange and unlikely official explanation, but possible. Stranger things have happened in the age of COVID-19.
Some people are drawing parallels with the death of another German doctor, Dr. Thomas Jendges, the managing director of Chemnitz Clinic and later, managing director of a large municipal hospital in the eastern part of Germany. The doctor died in early November 2021, deemed a suicide. On social media, rumors spread stating that he left a note and said, ‘’I no longer want to be a part of the genocide happening via the COVID-19 vaccine.’’ However, there is no evidence that he left such a note, with the Mayor of the town Chemnitz declaring that no suicide letter exists. According to Reuters, there is also no evidence that Dr. Jendges was against vaccines. Here is a video of Dr Jendges speaking out before his untimely death.
It’s possible but unlikely that controversial figures such as these outspoken scientists are on some sort of watch list. There are some forms of precedent when industry had big blockbuster products with outspoken critics. During this pandemic Merck most certainly took an active role against the ivermectin studies—making controversial statements about ivermectin, as reported by TrialSite. Disturbingly, back in 2009 the company compiled a hit list of anti-Vioxx doctors to destroy, neutralize, or discredit
Someday the Playground will return to a semblance of what is considered 'normal' debate on physics found here. Inevitably, this Covid conversation will end. Perhaps it could move to a chat room or elsewhere?
Meanwhile I'll add this...
Times
POSTED ONMAY 16, 2013
Wikipedia Beyond Cold Fusion: A Journey Into the Depths of Wiki Science
It has been noted by many that the Wikipedia Cold Fusion article is not a good source for those seeking information on the art of this science. The Wiki article quibbles as to whether cold fusion research is actually science. The Wiki article also does not recognize the peer review process of LENR-CANR.org or other cold fusion science journals; seeing them as publications by a group of self promoting crackpot scientists, deluding us and each other with dreams of infinite energy akin to perpetual motion, i.e. pseudoscience. This limits valid source material, turning Wiki Cold Fusion into a battle ground and a poor encyclopedic science article with a very low Wiki rating.
To get to the heart of this matter, we will go beyond the surface of the field of battle at the Wiki cold fusion article and find, there in the depths of Wikipedia, the workings of the science behind the clean low energy nuclear reaction environment; now emerging into the marketplace as popular ‘cold fusion’ LENR energy.
It is heartening to find, in Wikipedia, science that challenges known theory; and which confirms the science and the physics surrounding the low energy nuclear reaction. Here we have proof that the coverage of cutting edge cold fusion research has been sorely mistreated by the senior Wiki editors who ride that post. Explore the depths of Wiki science and find that nowhere else is cutting edge research which challenges known theory thrown into such a battleground of contention, as is found at the Wikipedia article about Cold Fusion… Now, why with recent developments is this so?
Explore Key Words at Wiki From This Cold Fusion (LENR) Patent
“Method for Producing Heavy Electrons”, NASA LENR Patent (USPTO link)
Surface plasmons (SPs), Surface plasmon polaritons (SPPs), Resonant frequency, Heavy electrons, Metal hydride, Fractal geometry, Energy, Unconventional superconductivity, Weak antiferromagnetism, Pseudo metamagnetism, Hydrogenated/deuterated molecular structures such as graphane and its nanotube variants, Quasi-crystalline arrays, Metamaterials, Dusty plasmas
Surface plasmons (SPs) are coherent electron oscillations that exist at the interface between any two materials where the real part of the dielectric function changes sign across the interface (e.g. a metal-dielectric interface, such as a metal sheet in air). SPs have lower energy than bulk (or volume) plasmons which quantise the longitudinal electron oscillations about positive ion cores within the bulk of an electron gas (or plasma). The existence of surface plasmons was first predicted in 1957 by Rufus Ritchie. In the following two decades, surface plasmons were extensively studied by many scientists, the foremost of whom were T. Turbadar in the 1950s and 1960s, and Heinz Raether, E. Kretschmann, and A. Otto in the 1960s and 1970s. Information transfer in nanoscale structures, similar to photonics, by means of surface plasmons, is referred to as plasmonics. Surface plasmons can be excited by both electrons and photons. (Wiki)
Surface plasmon polaritons (SPPs), are infrared or visible frequency electromagnetic waves trapped at or guided along metal-dielectric interfaces. These are shorter in wavelength than the incident light (photons). Hence, SPPs can provide a significant reduction in effective wavelength and a corresponding significant increase in spatial confinement and local field intensity. Collective charge oscillations at the boundary between an insulating dielectric medium (such as air or glass) and a metal (such as gold, silver or copper) are able to sustain the propagation of infrared or visible frequency electromagnetic waves known as surface plasmon-polaritons (SPP). SPPs are guided along metal-dielectric interfaces much in the same way light can be guided by an optical fiber, with the unique characteristic of subwavelength-scale confinement perpendicular to the interface. Surface plasmons (not SPPs), occur as light induced packets of electrical charges collectively oscillate at the surfaces of metals at optical frequencies.
Under specific conditions, the light that radiates the object (incident light) couples with the surface plasmons to create self-sustaining, propagating electromagnetic waves known as surface plasmon polaritons (SPPs). Once launched, the SPPs ripple along the metal-dielectric interface and do not stray from this narrow path. Compared with the incident light that triggered the transformation, the SPPs can be much shorter in wavelength. In other words, when SPs couple with a photon, the resulting hybridised excitation is called a surface plasmon polariton (SPP). This SPP can propagate along the surface of a metal until energy is lost either via absorption in the metal or radiation into free-space. (Wiki)
Resonant frequencies In physics, resonance is the tendency of a system to oscillate with greater amplitude at some frequencies than at others. Frequencies at which the response amplitude is a relative maximum are known as the system’s resonant frequencies, or resonance frequencies. At these frequencies, even small periodic driving forces can produce large amplitude oscillations, because the system stores vibrational energy. Resonance occurs when a system is able to store and easily transfer energy between two or more different storage modes (such as kinetic energy and potential energy in the case of a pendulum). Resonance phenomena occur with all types of vibrations or waves: there is mechanical resonance, acoustic resonance, electromagnetic resonance, nuclear magnetic resonance (NMR), electron spin resonance (ESR), and resonance of quantum wave functions. (Wiki)
Muons (mu mesons aka heavy electrons) Muons are denoted by μ− and antimuons by μ+. Muons were previously called mu mesons, but are not classified as mesons by modern particle physicists (see History). Muons have a mass of 105.7 MeV/c2, which is about 200 times the mass of an electron. Since the muon’s interactions are very similar to those of the electron, a muon can be thought of as a much heavier version of the electron. The eventual recognition of the “mu meson” muon as a simple “heavy electron” with no role at all in the nuclear interaction, seemed so incongruous and surprising at the time, that Nobel laureate I. I. Rabi famously quipped, “Who ordered that?” Muonic helium is created by substituting a muon for one of the electrons in helium-4. The muon orbits much closer to the nucleus, so muonic helium can therefore be regarded like an isotope of hydrogen whose nucleus consists of two neutrons, two protons and a muon, with a single electron outside. Colloquially, it could be called “hydrogen 4.1”, since the mass of the muon is roughly 0.1 au. Chemically, muonic helium, possessing an unpaired valence electron, can bond with other atoms, and behaves more like a hydrogen atom than an inert helium atom. A positive muon, when stopped in ordinary matter, can also bind an electron and form an exotic atom known as muonium (Mu) atom, in which the muon acts as the nucleus. The positive muon, in this context, can be considered a pseudo-isotope of hydrogen with one ninth of the mass of the proton. Because the reduced mass of muonium, and hence its Bohr radius, is very close to that of hydrogen, this short-lived “atom” behaves chemically — to a first approximation — like hydrogen, deuterium and tritium. Since the production of muons requires an available center of momentum frame energy of 105.7 MeV, neither ordinary radioactive decay events nor nuclear fission and fusion events (such as those occurring in nuclear reactors and nuclear weapons) are energetic enough to produce muons. Only nuclear fission produces single-nuclear-event energies in this range, but does not produce muons as the production of a single muon is possible only through the weak interaction, which does not take part in a nuclear fission. (Wiki)
Metal hydrides Complex metal hydrides are salts wherein the anions contain hydrides. In the older chemical literature as well as contemporary materials science textbooks, a “metal hydride” is assumed to be nonmolecular, i.e. three-dimensional lattices of atomic ions. In such systems, hydrides are often interstitial and nonstoichiometric, and the bonding between the metal and hydrogen atoms is significantly ionic. In contrast, complex metal hydrides typically contain more than one type of metal or metalloid and may be soluble but invariably react with water. (Wiki)
Fractal Geometry One often cited description that Mandelbrot published to describe geometric fractals is “a rough or fragmented geometric shape that can be split into parts, each of which is (at least approximately) a reduced-size copy of the whole”; this is generally helpful but limited. Authorities disagree on the exact definition of fractal, but most usually elaborate on the basic ideas of self-similarity and an unusual relationship with the space a fractal is embedded in. One point agreed on is that fractal patterns are characterized by fractal dimensions, but whereas these numbers quantify complexity (i.e., changing detail with changing scale), they neither uniquely describe nor specify details of how to construct particular fractal patterns. Multifractal scaling: characterized by more than one fractal dimension or scaling rule. Fine or detailed structure at arbitrarily small scales. A consequence of this structure is fractals may have emergent properties; irregularity locally and globally that is not easily described in traditional Euclidean geometric language. (Wiki)
Energy In physics, energy is an indirectly observed quantity which comes in many forms, such as kinetic energy, potential energy, radiant energy, and many others; which are listed in this summary article. This is a major topic in science and technology and this article gives an overview of its major aspects, and provides links to the many specific articles about energy in its different forms and contexts. The question “what is energy?” is difficult to answer in a simple, intuitive way, although energy can be rigorously defined in theoretical physics. In the words of Richard Feynman, “It is important to realize that in physics today, we have no knowledge what energy is. We do not have a picture that energy comes in little blobs of a definite amount.” Whenever physical scientists discover that a certain phenomenon appears to violate the law of energy conservation, new forms may be added, as is the case with dark energy, a hypothetical form of energy that permeates all of space and tends to increase the rate of expansion of the universe. (Wiki)
Unconventional Superconductors are materials that display superconductivity which does not conform to either the conventional BCS theory or the Nikolay Bogolyubov’s theory or its extensions. After more than twenty years of intensive research the origin of high-temperature superconductivity is still not clear, but it seems that instead of electron-phonon attraction mechanisms, as in conventional superconductivity, one is dealing with genuine electronic mechanisms (e.g. by antiferromagnetic correlations), and instead of s-wave pairing, d-waves are substantial. One goal of all this research is room-temperature superconductivity . A room-temperature superconductor is a hypothetical material which would be capable of exhibiting superconductivity at operating temperatures above 0° C (273.15 K). While this is not strictly “room temperature” (which would be approx. 20–25 °C), it is the temperature at which ice forms and can be reached and maintained easily in an everyday environment. At present, the highest temperature superconducting materials are the cuprates, which have demonstrated superconductivity at atmospheric pressure at temperatures as high as -135 °C (138 K). It is unknown whether any material exhibiting room-temperature superconductivity exists. The interest in its discovery arises from the repeated discovery of superconductivity at temperatures previously unexpected or held to be impossible. The potential benefits for society and science if such a material did exist are profound. (Wiki)
Weak antiferromagnetism One of the fundamental properties of an electron (besides that it carries charge) is that it has a dipole moment, i.e., it behaves itself as a tiny magnet. This dipole moment comes from the more fundamental property of the electron that it has quantum mechanical spin. The quantum mechanical nature of this spin causes the electron to only be able to be in two states, with the magnetic field either pointing “up” or “down” (for any choice of up and down). The spin of the electrons in atoms is the main source of ferromagnetism, although there is also a contribution from the orbital angular momentum of the electron about the nucleus. When these tiny magnetic dipoles are aligned in the same direction, their individual magnetic fields add together to create a measurable macroscopic field. However, in materials with a filled electron shell, the total dipole moment of the electrons is zero because the spins are in up/down pairs. Only atoms with partially filled shells (i.e., unpaired spins) can have a net magnetic moment, so ferromagnetism only occurs in materials with partially filled shells. Because of Hund’s rules, the first few electrons in a shell tend to have the same spin, thereby increasing the total dipole moment. These unpaired dipoles (often called simply “spins” even though they also generally include angular momentum) tend to align in parallel to an external magnetic field, an effect called paramagnetism. Ferromagnetism involves an additional phenomenon, however: The dipoles tend to align spontaneously, giving rise to a spontaneous magnetization, even when there is no applied field. Diamagnetism Diamagnetism is a magnetic response shared by all substances. In response to an applied magnetic field, electrons precess (see Larmor precession), and by Lenz’s law they act to shield the interior of a body from themagnetic field. Thus, the moment produced is in the opposite direction to the field and the susceptibility is negative. This effect is weak but independent of temperature. A substance whose only magnetic response is diamagnetism is called a diamagnet. Paramagnetism Paramagnetism is a weak positive response to a magnetic field due to rotation of electron spins. Paramagnetism occurs in certain kinds of iron-bearing minerals because the iron contains an unpaired electron in one of their shells (see Hund’s rules). Some are paramagnetic down to absolute zero and their susceptibility is inversely proportional to the temperature (see Curie’s law); others are magnetically ordered below a critical temperature and the susceptibility increases as it approaches that temperature (see Curie-Weiss law). Ferromagnetism Collectively, strongly magnetic materials are often referred to as ferromagnets. However, this magnetism can arise as the result of more than one kind of magnetic order. In the strict sense, ferromagnetism refers to magnetic ordering where neighboring electron spins are aligned by the exchange interaction. Below a critical temperature called the Curie temperature, ferromagnets have a spontaneous magnetization and there is hysteresis in their response to a changing magnetic field. Most importantly for rock magnetism, they have remanence, so they can record the Earth’s field. Iron does not occur widely in its pure form. It is usually incorporated into iron oxides, oxyhydroxides and sulfides. In these compounds, the iron atoms are not close enough for direct exchange, so they are coupled by indirect exchange or superexchange. The result is that the crystal lattice is divided into two or more sublattices with different moments. Ferrimagetism Ferrimagnets have two sublattices with opposing moments. One sublattice has a larger moment, so there is a net unbalance. Ferrimagnets often behave like ferromagnets, but the temperature dependence of their spontaneous magnetization can be quite different. Louis Néel identified four types of temperature dependence, one of which involves a reversal of the magnetization. This phenomenon played a role in controversies over marine magnetic anomalies. Antiferromagnetism Antiferromagnets, like ferrimagnets, have two sublattices with opposing moments, but now the moments are equal in magnitude. If the moments are exactly opposed, the magnet has no remanence. However, the moments can be tilted (spin canting), resulting in a moment nearly at right angles to the moments of the sublattices. (Wiki)
Metamagnetism is a blanket term used loosely in physics to describe a sudden (often, dramatic) increase in the magnetization of a material with a small change in an externally applied magnetic field. The metamagnetic behavior may have quite different physical causes for different types of metamagnets. Some examples of physical mechanisms leading to metamagnetic behavior are: Itinerant Metamagnetism – Exchange splitting of the Fermi surface in a paramagnetic system of itinerant electrons causes an energetically favorable transition to bulk magnetization near the transition to a ferromagnet or other magnetically ordered state. Antiferromagnetic Transition – Field-induced spin flips in antiferromagnets cascade at a critical energy determined by the applied magnetic field. Depending on the material and experimental conditions, metamagnetism may be associated with a first-order phase transition, a continuous phase transition at a critical point(classical or quantum), or crossovers beyond a critical point that do not involve a phase transition at all. These wildly different physical explanations sometimes lead to confusion as to what the term “metamagnetic” is referring in specific cases. (Wiki)
Graphane is a two-dimensional polymer of carbon and hydrogen with the formula unit (CH)n where n is large. Graphane should not be confused with graphene, a two-dimensional form of carbon alone. Graphane is a form of hydrogenated graphene. Graphane’s carbon bonds are in sp3 configuration, as opposed to graphene’s sp2 bond configuration, thus graphane is a two-dimensional analog of cubic diamond. The first theoretical description of graphane was reported in 2003 and its preparation was reported in 2009. Full hydrogenation from both sides of a graphene sheet results in graphane, but partial hydrogenation leads to hydrogenated graphene. If graphene rests on a silica surface, hydrogenation on only one side of graphene preserves the hexagonal symmetry in graphane. One-sided hydrogenation of graphene becomes possible due to the existence of ripplings. Because the latter are distributed randomly, obtained graphane is expected to be disordered material in contrast to two-sided graphane. If Annealing allows the hydrogen to disperse, reverting to graphene. Note: p-doped graphane is postulated to be a high-temperature BCS theory superconductor with a Tc above 90 K. (Wiki)
Surface Layering (quasi-crystalline arrays) Surface layering is a quasi-crystalline structure at the surfaces of otherwise disordered liquids, where atoms or molecules of even the simplest liquid are stratified into well-defined layers parallel to the surface. While in crystalline solids such atomic layers can extend periodically throughout the entire dimension of a crystal, surface layering decays rapidly away from the surface and is limited to just a few near-surface region layers. Another difference between surface layering and crystalline structure is that atoms or molecules of surface-layered liquids are not ordered in-plane, while in crystalline solids they are. Surface layering was predicted theoretically by Stuart Rice at the University of Chicago in 1983 and has been experimentally discovered by Peter Pershan (Harvard) and his group, working in collaboration with Ben Ocko (Brookhaven) and Moshe Deutsch (Bar-Ilan) in 1995 in elemental liquid mercury and liquid gallium using x-ray reflectivity techniques. More recently layering has been shown to arise from electronic properties of metallic liquids, rather than thermodynamic variables such as surface tension, since surfaces of low-surface tension metallic liquids such as liquid potassium are layered, while those of dielectric liquids such as water, are not. (Wiki)
Metamaterials are artificial materials engineered to have properties that may not be found in nature. They are assemblies of multiple individual elements fashioned from conventional microscopic materials such as metals or plastics, but the materials are usually arranged in periodic patterns. Metamaterials gain their properties not from their composition, but from their exactingly-designed structures. Their precise shape, geometry, size, orientation and arrangement can affect the waves of light or sound in an unconventional manner, creating material properties which are unachievable with conventional materials. These metamaterials achieve desired effects by incorporating structural elements of sub-wavelength sizes, i.e. features that are actually smaller than the wavelength of the waves they affect. (Wiki)
Plasmonic metamaterials are metamaterials that exploit surface plasmons, which are produced from the interaction of light with metal-dielectric materials. Under specific conditions, the incident light couples with the surface plasmons to create self-sustaining, propagating electromagnetic waves known as surface plasmon polaritons (SPPs). Once launched, the SPPs ripple along the metal-dielectric interface and do not stray from this narrow path. Compared with the incident light that triggered the transformation, the SPPs can be much shorter in wavelength. By fabricating such metamaterials fundamental limits tied to the wavelength of light are overcome. Light hitting a metamaterial is transformed into electromagnetic waves of a different variety—surface plasmon polaritons, which are shorter in wavelength than the incident light. This transformation leads to unusual and counterintuitive properties that might be harnessed for practical use. Moreover, new approaches that simplify the fabrication process of metamaterials are under development. This work also includes making new structures specifically designed to enable measurements of the materials novel properties. Furthermore, nanotechnology applications of these nanostructures are currently being researched, including microscopy beyond the diffraction limit. (Wiki)
Dusty Plasmas A dusty plasma is a plasma containing millimeter (10−3) to nanometer (10−9) sized particles suspended in it. Dust particles are charged and the plasma and particles behave as a plasma. Dust particles may form larger particles resulting in “grain plasmas”. Due to the additional complexity of studying plasmas with charged dust particles, dusty plasmas are also known as Complex Plasmas. Dusty plasmas are interesting because the presence of particles significantly alters the charged particle equilibrium leading to different phenomena. It is a field of current research. Electrostatic coupling between the grains can vary over a wide range so that the states of the dusty plasma can change from weakly coupled (gaseous) to crystalline. Such plasmas are of interest as a non-Hamiltonian system of interacting particles and as a means to study generic fundamental physics of self-organization, pattern formation, phase transitions, and scaling. (Wiki)
This brings us to the end of our exploration for now (there will be more of this Wiki series in the near future)
I hope you have enjoyed the trip. When reading the NASA LENR – Cold Fusion Patent after completing this journey, you may be surprised at the depth of your new insight. Also, please remember, when informing others about LENR – Cold Fusion Energy be sure to tell them… “Explore beyond the surface of ‘Wikipedia Cold Fusion’ and take a journey into the depths of Wiki science.”
Thanks,
Greg Goble
The New York Times piece shared that SARS-CoV-2 positivity rates track as high as 20% in children, yet “the vast majority were asymptomatic and arrived at the hospital with other health problems.”
I Guess the children go to hospital with RSV and fill the ICU - as all over the world since 3 months - and then test positive for SARS CoV-19... Fake - fear mongering...
The Reuters article states that the claims related to graphene oxide began with a report by Pablo Campra Madrid, a professor at the University of Almeria, Spain, in June 2021.
The Pfizer vaccines in fact contain graphene and graphenoxid as a later study done on 10 sample has proven.
